Is PACS or AGL more profitable?

PACS Group has a net margin of 4.49% compared to Agilon Health's net margin of -6.09%. PACS Group's return on equity of 26.47% beat Agilon Health's return on equity. Company Net Margins Return on Equity Return on Assets PACS Group 4.49% 26.47% 4.36% Agilon Health -6.09% -146.03% -24.55%

Does the media prefer PACS or AGL?

In the previous week, PACS Group had 12 more articles in the media than Agilon Health. MarketBeat recorded 16 mentions for PACS Group and 4 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.42 beat PACS Group's score of 0.07 indicating that Agilon Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 4 Very Positive mention(s) 7 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Agilon Health 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to BLLN or AGL?

In the previous week, Billiontoone had 13 more articles in the media than Agilon Health. MarketBeat recorded 17 mentions for Billiontoone and 4 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.42 beat Billiontoone's score of -0.17 indicating that Agilon Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 8 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Agilon Health 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is RDNT or AGL more profitable?

RadNet has a net margin of -0.66% compared to Agilon Health's net margin of -6.09%. RadNet's return on equity of 2.77% beat Agilon Health's return on equity. Company Net Margins Return on Equity Return on Assets RadNet -0.66% 2.77% 0.97% Agilon Health -6.09% -146.03% -24.55%

Does the media refer more to RDNT or AGL?

In the previous week, Agilon Health had 1 more articles in the media than RadNet. MarketBeat recorded 4 mentions for Agilon Health and 3 mentions for RadNet. RadNet's average media sentiment score of 1.38 beat Agilon Health's score of 0.42 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agilon Health 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is CELC or AGL more profitable?

Celcuity has a net margin of 0.00% compared to Agilon Health's net margin of -6.09%. Agilon Health's return on equity of -146.03% beat Celcuity's return on equity. Company Net Margins Return on Equity Return on Assets Celcuity N/A -244.61% -50.22% Agilon Health -6.09% -146.03% -24.55%

Does the media refer more to CELC or AGL?

In the previous week, Celcuity and Celcuity both had 4 articles in the media. Celcuity's average media sentiment score of 1.76 beat Agilon Health's score of 0.42 indicating that Celcuity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Agilon Health 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to CAI or AGL?

In the previous week, Caris Life Sciences had 5 more articles in the media than Agilon Health. MarketBeat recorded 9 mentions for Caris Life Sciences and 4 mentions for Agilon Health. Caris Life Sciences' average media sentiment score of 1.04 beat Agilon Health's score of 0.42 indicating that Caris Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Caris Life Sciences 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agilon Health 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Agilon Health (AGL) Competitors

$115.93 +1.08 (+0.94%)

Closing price 07/13/2026 03:59 PM Eastern

Extended Trading

$115.93 +0.00 (+0.00%)

As of 07/13/2026 07:39 PM Eastern

Compare

AGL vs. PACS, BLLN, RDNT, CELC, and CAI

Should you buy Agilon Health stock or one of its competitors? MarketBeat compares Agilon Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Agilon Health include PACS Group (PACS), Billiontoone (BLLN), RadNet (RDNT), Celcuity (CELC), and Caris Life Sciences (CAI). These companies are all part of the "healthcare" industry.

How does Agilon Health compare to PACS Group?

PACS Group (NYSE:PACS) and Agilon Health (NYSE:AGL) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, dividends and earnings.

PACS Group has a net margin of 4.49% compared to Agilon Health's net margin of -6.09%. PACS Group's return on equity of 26.47% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Agilon Health	-6.09%	-146.03%	-24.55%

PACS Group currently has a consensus price target of $50.60, suggesting a potential upside of 16.88%. Agilon Health has a consensus price target of $64.00, suggesting a potential downside of 44.79%. Given PACS Group's stronger consensus rating and higher probable upside, analysts clearly believe PACS Group is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Agilon Health	2 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.21

In the previous week, PACS Group had 12 more articles in the media than Agilon Health. MarketBeat recorded 16 mentions for PACS Group and 4 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.42 beat PACS Group's score of 0.07 indicating that Agilon Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	4 Very Positive mention(s)	7 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Agilon Health	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PACS Group has a beta of -0.08, meaning that its share price is 108% less volatile than the broader market. Comparatively, Agilon Health has a beta of 2.98, meaning that its share price is 198% more volatile than the broader market.

PACS Group has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.30	$191.54M	$1.56	27.75
Agilon Health	$5.93B	0.33	-$391.35M	-$21.56	N/A

Summary

PACS Group beats Agilon Health on 10 of the 13 factors compared between the two stocks.

How does Agilon Health compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Agilon Health (NYSE:AGL) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment and earnings.

Billiontoone has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	18.58	$7.45M	$0.55	224.09
Agilon Health	$5.93B	0.33	-$391.35M	-$21.56	N/A

In the previous week, Billiontoone had 13 more articles in the media than Agilon Health. MarketBeat recorded 17 mentions for Billiontoone and 4 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.42 beat Billiontoone's score of -0.17 indicating that Agilon Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	8 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Agilon Health	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Billiontoone has a net margin of 0.00% compared to Agilon Health's net margin of -6.09%. Billiontoone's return on equity of 0.00% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
Agilon Health	-6.09%	-146.03%	-24.55%

Billiontoone presently has a consensus target price of $126.00, suggesting a potential upside of 2.23%. Agilon Health has a consensus target price of $64.00, suggesting a potential downside of 44.79%. Given Billiontoone's stronger consensus rating and higher possible upside, equities analysts plainly believe Billiontoone is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Agilon Health	2 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.21

Summary

Billiontoone beats Agilon Health on 11 of the 13 factors compared between the two stocks.

How does Agilon Health compare to RadNet?

RadNet (NASDAQ:RDNT) and Agilon Health (NYSE:AGL) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment.

In the previous week, Agilon Health had 1 more articles in the media than RadNet. MarketBeat recorded 4 mentions for Agilon Health and 3 mentions for RadNet. RadNet's average media sentiment score of 1.38 beat Agilon Health's score of 0.42 indicating that RadNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Agilon Health	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

RadNet has higher earnings, but lower revenue than Agilon Health. RadNet is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.44	-$18.65M	-$0.18	N/A
Agilon Health	$5.93B	0.33	-$391.35M	-$21.56	N/A

RadNet currently has a consensus target price of $87.43, suggesting a potential upside of 38.10%. Agilon Health has a consensus target price of $64.00, suggesting a potential downside of 44.79%. Given RadNet's stronger consensus rating and higher probable upside, equities analysts clearly believe RadNet is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
Agilon Health	2 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.21

RadNet has a beta of 1.37, meaning that its stock price is 37% more volatile than the broader market. Comparatively, Agilon Health has a beta of 2.98, meaning that its stock price is 198% more volatile than the broader market.

RadNet has a net margin of -0.66% compared to Agilon Health's net margin of -6.09%. RadNet's return on equity of 2.77% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
Agilon Health	-6.09%	-146.03%	-24.55%

77.9% of RadNet shares are owned by institutional investors. 5.6% of RadNet shares are owned by insiders. Comparatively, 2.5% of Agilon Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

RadNet beats Agilon Health on 13 of the 17 factors compared between the two stocks.

How does Agilon Health compare to Celcuity?

Celcuity (NASDAQ:CELC) and Agilon Health (NYSE:AGL) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

Celcuity presently has a consensus price target of $152.09, suggesting a potential upside of 46.54%. Agilon Health has a consensus price target of $64.00, suggesting a potential downside of 44.79%. Given Celcuity's stronger consensus rating and higher possible upside, equities research analysts plainly believe Celcuity is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Agilon Health	2 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.21

In the previous week, Celcuity and Celcuity both had 4 articles in the media. Celcuity's average media sentiment score of 1.76 beat Agilon Health's score of 0.42 indicating that Celcuity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Agilon Health	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Celcuity has a beta of 0.16, meaning that its share price is 84% less volatile than the broader market. Comparatively, Agilon Health has a beta of 2.98, meaning that its share price is 198% more volatile than the broader market.

63.3% of Celcuity shares are owned by institutional investors. 13.3% of Celcuity shares are owned by company insiders. Comparatively, 2.5% of Agilon Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Celcuity has higher earnings, but lower revenue than Agilon Health. Celcuity is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Agilon Health	$5.93B	0.33	-$391.35M	-$21.56	N/A

Celcuity has a net margin of 0.00% compared to Agilon Health's net margin of -6.09%. Agilon Health's return on equity of -146.03% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Agilon Health	-6.09%	-146.03%	-24.55%

Summary

Celcuity beats Agilon Health on 9 of the 14 factors compared between the two stocks.

How does Agilon Health compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and Agilon Health (NYSE:AGL) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, media sentiment, valuation and risk.

Caris Life Sciences currently has a consensus target price of $26.11, suggesting a potential upside of 53.05%. Agilon Health has a consensus target price of $64.00, suggesting a potential downside of 44.79%. Given Caris Life Sciences' stronger consensus rating and higher possible upside, research analysts plainly believe Caris Life Sciences is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45
Agilon Health	2 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.21

Caris Life Sciences has a net margin of 3.75% compared to Agilon Health's net margin of -6.09%. Caris Life Sciences' return on equity of 98.28% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	3.75%	98.28%	48.87%
Agilon Health	-6.09%	-146.03%	-24.55%

In the previous week, Caris Life Sciences had 5 more articles in the media than Agilon Health. MarketBeat recorded 9 mentions for Caris Life Sciences and 4 mentions for Agilon Health. Caris Life Sciences' average media sentiment score of 1.04 beat Agilon Health's score of 0.42 indicating that Caris Life Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Caris Life Sciences	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Agilon Health	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Caris Life Sciences has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$812.03M	5.94	-$68.09M	-$7.61	N/A
Agilon Health	$5.93B	0.33	-$391.35M	-$21.56	N/A

Summary

Caris Life Sciences beats Agilon Health on 12 of the 13 factors compared between the two stocks.

Get Agilon Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AGL vs. The Competition

Export

Metric	Agilon Health	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$1.92B	$9.60B	$7.05B	$23.46B
Dividend Yield	N/A	1.62%	2.68%	4.02%
P/E Ratio	-5.38	26.00	27.11	31.08
Price / Sales	0.33	17.40	589.14	19.77
Price / Cash	N/A	14.81	29.22	18.64
Price / Book	15.17	6.05	10.75	4.77
Net Income	-$391.35M	$177.20M	$3.58B	$1.06B
7 Day Performance	7.52%	-2.07%	-2.10%	-0.23%
1 Month Performance	2.65%	6.96%	3.29%	-0.11%
1 Year Performance	106.55%	11.42%	26.32%	16.46%

Agilon Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AGL Agilon Health	1.1373 of 5 stars	$115.93 +0.9%	$64.00 -44.8%	+107.9%	$1.92B	$5.93B	N/A	1,076	Analyst Forecast
PACS PACS Group	3.3629 of 5 stars	$44.68 +0.5%	$48.00 +7.4%	+242.5%	$7.04B	$5.29B	28.51	47,455
BLLN Billiontoone	1.7403 of 5 stars	$123.40 +2.5%	$126.00 +2.1%	N/A	$5.54B	$305.11M	N/A	620	News Coverage Insider Trade
RDNT RadNet	3.6025 of 5 stars	$68.92 +0.2%	$87.43 +26.9%	+14.1%	$5.41B	$2.04B	N/A	11,264	Positive News
CELC Celcuity	3.6983 of 5 stars	$108.58 +0.6%	$152.09 +40.1%	+661.5%	$5.26B	N/A	N/A	40	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AGL) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agilon Health (AGL) Competitors

AGL vs. PACS, BLLN, RDNT, CELC, and CAI

How does Agilon Health compare to PACS Group?

Summary

How does Agilon Health compare to Billiontoone?

Summary

How does Agilon Health compare to RadNet?

Summary

How does Agilon Health compare to Celcuity?

Summary

How does Agilon Health compare to Caris Life Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGL vs. The Competition

Agilon Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Agilon Health (AGL) Competitors

AGL vs. PACS, BLLN, RDNT, CELC, and CAI

How does Agilon Health compare to PACS Group?

Is PACS or AGL more profitable?

Do analysts rate PACS or AGL?

Does the media prefer PACS or AGL?

Which has more risk & volatility, PACS or AGL?

Which has preferable valuation & earnings, PACS or AGL?

Summary

How does Agilon Health compare to Billiontoone?

Which has stronger earnings and valuation, BLLN or AGL?

Does the media refer more to BLLN or AGL?

Is BLLN or AGL more profitable?

Do analysts rate BLLN or AGL?

Summary

How does Agilon Health compare to RadNet?

Does the media refer more to RDNT or AGL?

Which has better earnings and valuation, RDNT or AGL?

Do analysts prefer RDNT or AGL?

Which has more volatility and risk, RDNT or AGL?

Is RDNT or AGL more profitable?

Do institutionals and insiders hold more shares of RDNT or AGL?

Summary

How does Agilon Health compare to Celcuity?

Do analysts prefer CELC or AGL?

Does the media refer more to CELC or AGL?

Which has more volatility & risk, CELC or AGL?

Do insiders and institutionals hold more shares of CELC or AGL?

Which has higher valuation and earnings, CELC or AGL?

Is CELC or AGL more profitable?

Summary

How does Agilon Health compare to Caris Life Sciences?

Do analysts rate CAI or AGL?

Is CAI or AGL more profitable?

Does the media refer more to CAI or AGL?

Which has preferable earnings & valuation, CAI or AGL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGL vs. The Competition

Agilon Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools